Cargando…
Tnfrsf12a-Mediated Atherosclerosis Signaling and Inflammatory Response as a Common Protection Mechanism of Shuxuening Injection Against Both Myocardial and Cerebral Ischemia-Reperfusion Injuries
Shuxuening injection (SXNI) is a widely prescribed herbal medicine of Ginkgo biloba extract (EGB) for cerebral and cardiovascular diseases in China. However, its curative effects on ischemic stroke and heart diseases and the underlying mechanisms remain unknown. Taking an integrated approach of RNA-...
Autores principales: | Lyu, Ming, Cui, Ying, Zhao, Tiechan, Ning, Zhaochen, Ren, Jie, Jin, Xingpiao, Fan, Guanwei, Zhu, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5897438/ https://www.ncbi.nlm.nih.gov/pubmed/29681850 http://dx.doi.org/10.3389/fphar.2018.00312 |
Ejemplares similares
-
Effectiveness of Shuxuening injection in coronary heart disease: a systematic review and meta-analysis
por: Shi, Menglong, et al.
Publicado: (2023) -
Systematic Review of the Efficacy and Safety of Shuxuening Injection in the Treatment of Unstable Angina
por: Fan, Genhao, et al.
Publicado: (2022) -
Reevaluation of the post-marketing safety of Shuxuening injection based on real-world and evidence-based evaluations
por: Wang, Can, et al.
Publicado: (2018) -
CXCR1 and its downstream NF-κB inflammation signaling pathway as a key target of Guanxinning injection for myocardial ischemia/reperfusion injury
por: Xiao, Guangxu, et al.
Publicado: (2022) -
A powerful on line ABTS(+)–CE-DAD method to screen and quantify major antioxidants for quality control of Shuxuening Injection
por: Ma, Huifen, et al.
Publicado: (2018)